BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 8357468)

  • 1. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
    Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro Metabolic Stability of Sterically Shielded Antimycobacterial Phenylalanine Amides.
    Lang M; Ganapathy US; Mann L; Seidel RW; Goddard R; Erdmann F; Dick T; Richter A
    ChemMedChem; 2024 Mar; 19(6):e202300593. PubMed ID: 38329388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives.
    Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
    Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
    Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
    Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antimycobacterial derivatives of benzoxazine.
    Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
    Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BM 212 and its derivatives as a new class of antimycobacterial active agents.
    Biava M
    Curr Med Chem; 2002 Nov; 9(21):1859-69. PubMed ID: 12369872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of mycobacterial resistance (especially Mycobacterium tuberculosis).
    Fischer B
    Chemotherapy; 1999; 45(2):109-20. PubMed ID: 10050058
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
    Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
    Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.